Neuropathy due to Chemotherapy

Patient presents with complaints consistent with chemotherapy-induced peripheral neuropathy (CIPN).  Symptoms include peripheral paresthesias, numbness, and dysesthesia in a stocking-glove distribution, impacting sensory function.  Onset of symptoms correlated with recent chemotherapy treatment with (specify chemotherapeutic agent, e.g., oxaliplatin, paclitaxel).  Neurological examination reveals decreased sensation to light touch and pinprick in the distal extremities.  Patient reports difficulties with fine motor skills and balance.  Assessment suggests Grade (specify grade based on NCI-CTCAE grading scale for CIPN) peripheral neuropathy secondary to chemotherapy.  Differential diagnosis includes diabetic neuropathy, alcoholic neuropathy, and vitamin B12 deficiency.  These were ruled out based on patient history, laboratory results (HbA1c, B12 levels), and clinical presentation.  Plan includes patient education regarding neuropathic pain management strategies, including medication management with (specify medication, e.g., gabapentin, duloxetine), physical therapy for balance and gait training, and occupational therapy for adaptive equipment and strategies to improve activities of daily living.  Patient advised to avoid further exposure to neurotoxic agents where possible.  Follow-up scheduled to monitor symptom progression and treatment efficacy.  ICD-10 code G62.81 (Toxic neuropathy) and G92.0 (Poisoning by antineoplastic and immunosuppressive drugs) are considered.  CPT codes for evaluation and management, as well as any procedures performed, will be documented separately.